These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 35507499)

  • 21. Prophylactic catheter ablation for the prevention of defibrillator therapy.
    Reddy VY; Reynolds MR; Neuzil P; Richardson AW; Taborsky M; Jongnarangsin K; Kralovec S; Sediva L; Ruskin JN; Josephson ME
    N Engl J Med; 2007 Dec; 357(26):2657-65. PubMed ID: 18160685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): an on-treatment analysis.
    Delacrétaz E; Brenner R; Schaumann A; Eckardt L; Willems S; Pitschner HF; Kautzner J; Schumacher B; Hansen PS; Kuck KH;
    J Cardiovasc Electrophysiol; 2013 May; 24(5):525-9. PubMed ID: 23350967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patients treated with catheter ablation for ventricular tachycardia after an ICD shock have lower long-term rates of death and heart failure hospitalization than do patients treated with medical management only.
    Bunch TJ; Weiss JP; Crandall BG; Day JD; May HT; Bair TL; Osborn JS; Mallender C; Fischer A; Brunner KJ; Mahapatra S
    Heart Rhythm; 2014 Apr; 11(4):533-40. PubMed ID: 24333283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rationale and design of BERLIN VT study: a multicenter randomised trial comparing preventive versus deferred ablation of ventricular tachycardia.
    Tilz RR; Kuck KH; Kääb S; Wegscheider K; Thiem A; Wenzel B; Willems S; Steven D
    BMJ Open; 2019 May; 9(5):e022910. PubMed ID: 31072848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The efficacy of catheter ablation versus ICD for prevention of ventricular tachycardia in patients with ischemic heart disease: a systematic review and meta-analysis.
    Liu G; Xu X; Yi Q; Lv T
    J Interv Card Electrophysiol; 2021 Sep; 61(3):435-443. PubMed ID: 33723693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
    Sapp JL; Wells GA; Parkash R; Stevenson WG; Blier L; Sarrazin JF; Thibault B; Rivard L; Gula L; Leong-Sit P; Essebag V; Nery PB; Tung SK; Raymond JM; Sterns LD; Veenhuyzen GD; Healey JS; Redfearn D; Roux JF; Tang AS
    N Engl J Med; 2016 Jul; 375(2):111-21. PubMed ID: 27149033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence and predictors of mortality following ablation of ventricular tachycardia in patients with an implantable cardioverter-defibrillator.
    Sauer WH; Zado E; Gerstenfeld EP; Marchlinski FE; Callans DJ
    Heart Rhythm; 2010 Jan; 7(1):9-14. PubMed ID: 19939743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes Associated With Catheter Ablation of Ventricular Tachycardia in Patients With Cardiac Sarcoidosis.
    Siontis KC; Santangeli P; Muser D; Marchlinski FE; Zeppenfeld K; Hoogendoorn JC; Narasimhan C; Sauer WH; Zipse MM; Kapa S; Vedantham V; Rosenthal DG; Robinson MR; Patton KK; Murgatroyd F; Chicos AB; Soejima K; Roukoz H; Sacher F; Bhan A; Appelbaum J; Dickfeld T; Mankad P; Ellenbogen KA; Kron J; Kim HM; Froehlich J; Eagle KA; Bogun FM; Crawford TC
    JAMA Cardiol; 2022 Feb; 7(2):175-183. PubMed ID: 34787643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A systematic review and meta-analysis comparing radiofrequency catheter ablation with medical therapy for ventricular tachycardia in patients with ischemic and non-ischemic cardiomyopathies.
    Ravi V; Poudyal A; Khanal S; Khalil C; Vij A; Sanders D; Larsen T; Trohman RG; Aksu T; Tung R; Santangeli P; Winterfield J; Sharma PS; Huang HD
    J Interv Card Electrophysiol; 2023 Jan; 66(1):161-175. PubMed ID: 35759160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ventricular arrhythmia inducibility predicts subsequent ICD activation in nonischemic cardiomyopathy patients: a DEFINITE substudy.
    Daubert JP; Winters SL; Subacius H; Berger RD; Ellenbogen KA; Taylor SG; Schaechter A; Howard A; Kadish A;
    Pacing Clin Electrophysiol; 2009 Jun; 32(6):755-61. PubMed ID: 19545338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Prospective, Multicentre Randomised Controlled Trial Comparing Catheter Ablation Versus Antiarrhythmic Drugs in Patients With Structural Heart Disease Related Ventricular Tachycardia: The CAAD-VT Trial Protocol.
    ; Bennett RG; Campbell T; Garikapati K; Kotake Y; Turnbull S; Kanawati J; Wong MS; Qian P; Thomas SP; Chow CK; Kovoor P; Robert Denniss A; Chik W; Marschner S; Kistler P; Haqqani H; Rowe M; Voskoboinik A; Lee G; Jackson N; Sanders P; Roberts-Thomson K; Chan KH; Sy R; Pathak R; Kanagaratnam L; Chia K; El-Sokkari I; Hallani H; Kanthan A; Burgess D; Kumar S
    Heart Lung Circ; 2023 Feb; 32(2):184-196. PubMed ID: 36599791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN Trial.
    Knops RE; van der Stuijt W; Delnoy PPHM; Boersma LVA; Kuschyk J; El-Chami MF; Bonnemeier H; Behr ER; Brouwer TF; Kääb S; Mittal S; Quast ABE; Smeding L; Tijssen JGP; Bijsterveld NR; Richter S; Brouwer MA; de Groot JR; Kooiman KM; Lambiase PD; Neuzil P; Vernooy K; Alings M; Betts TR; Bracke FALE; Burke MC; de Jong JSSG; Wright DJ; Jansen WPJ; Whinnet ZI; Nordbeck P; Knaut M; Philbert BT; van Opstal JM; Chicos AB; Allaart CP; Borger van der Burg AE; Clancy JF; Dizon JM; Miller MA; Nemirovsky D; Surber R; Upadhyay GA; Weiss R; de Weger A; Wilde AAM; Olde Nordkamp LRA;
    Circulation; 2022 Feb; 145(5):321-329. PubMed ID: 34779221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sex Differences in the Risk of First and Recurrent Ventricular Tachyarrhythmias Among Patients Receiving an Implantable Cardioverter-Defibrillator for Primary Prevention.
    Saxena S; Goldenberg I; McNitt S; Hsich E; Kutyifa V; Bragazzi NL; Polonsky B; Aktas MK; Huang DT; Rosero S; Klein H; Zareba W; Younis A
    JAMA Netw Open; 2022 Jun; 5(6):e2217153. PubMed ID: 35699956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Follow-up after hemodynamically not tolerated ventricular tachycardia in patients with midrange reduced to normal ejection fraction: A retrospective single-centre case series.
    Groeneveld SA; Blom LJ; van der Heijden JF; Loh P; Hassink RJ
    Eur J Clin Invest; 2021 Jan; 51(1):e13359. PubMed ID: 32705678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-density substrate-guided ventricular tachycardia ablation: role of activation mapping in an attempt to improve procedural effectiveness.
    Carbucicchio C; Ahmad Raja N; Di Biase L; Volpe V; Dello Russo A; Trivedi C; Bartoletti S; Zucchetti M; Casella M; Russo E; Santangeli P; Moltrasio M; Tundo F; Fassini G; Natale A; Tondo C
    Heart Rhythm; 2013 Dec; 10(12):1850-8. PubMed ID: 24055940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ablation of Refractory Ventricular Tachycardia Using Intramyocardial Needle Delivered Heated Saline-Enhanced Radiofrequency Energy: A First-in-Man Feasibility Trial.
    Packer DL; Wilber DJ; Kapa S; Dyrda K; Nault I; Killu AM; Kanagasundram A; Richardson T; Stevenson W; Verma A; Curley M;
    Circ Arrhythm Electrophysiol; 2022 Aug; 15(8):e010347. PubMed ID: 35776711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and mid-term outcome of catheter ablation of ventricular tachycardia in octogenarians.
    Frontera A; Panniker S; Breitenstein A; Bruno VD; Connolly GM; Wilson D; Rio T; Dhinoja MB; Hussain W; Schilling RJ; Thomas G; Wong T; Hunter RJ; Sacher F; Jaïs P; Duncan E
    Europace; 2017 Aug; 19(8):1369-1377. PubMed ID: 27974359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Baseline Antiarrhythmic Drug on Outcomes With Ablation in Ischemic Ventricular Tachycardia: A VANISH Substudy (Ventricular Tachycardia Ablation Versus Escalated Antiarrhythmic Drug Therapy in Ischemic Heart Disease).
    Parkash R; Nault I; Rivard L; Gula L; Essebag V; Nery P; Tung S; Raymond JM; Sterns L; Doucette S; Wells G; Tang ASL; Stevenson WG; Sapp JL
    Circ Arrhythm Electrophysiol; 2018 Jan; 11(1):e005663. PubMed ID: 29305400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Case report and review about radiofrequency catheter ablation in a patient with dilated cardiomyopathy and an implantable cardioverter defibrillator].
    Lepillier A; Paziaud O; Lascault G; Copie X; Piot O
    Ann Cardiol Angeiol (Paris); 2009 Feb; 58(1):34-9. PubMed ID: 18667195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends and Outcomes of Catheter Ablation for Ventricular Tachycardia in a Community Cohort.
    Yousuf OK; Zusterzeel R; Sanders W; Caños D; Dekmezian C; Silverman H; Calkins H; Berger R; Tandri H; Nazarian S; Strauss DG
    JACC Clin Electrophysiol; 2018 Sep; 4(9):1189-1199. PubMed ID: 30236393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.